Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_000417.2(IL2RA):c.497G>A (p.Ser166Asn) | 3559 | IL2RA | Pathogenic | 796051887 | RCV000185641; | N | MedGen:C1853392,OMIM:606367,ORPHA:169100 | 10 | 6063527 | 6063527 | NM_000417.2:c.497G>A | NP_000408.1:p.Ser166Asn | NC_000010.10:g.6063527C>T | OMIM Allelic Variant:147730.0006 | C1868570 169100 Char syndrome; C1853392 606367 Interleukin 2 receptor, alpha, deficiency of | | |
NM_000417.2(IL2RA):c.122A>C (p.Tyr41Ser) | 3559 | IL2RA | Pathogenic | 796051888 | RCV000185642; | N | MedGen:C1853392,OMIM:606367,ORPHA:169100 | 10 | 6067931 | 6067931 | NM_000417.2:c.122A>C | NP_000408.1:p.Tyr41Ser | NC_000010.10:g.6067931T>G | OMIM Allelic Variant:147730.0007 | C1868570 169100 Char syndrome; C1853392 606367 Interleukin 2 receptor, alpha, deficiency of | | |
NM_003221.3(TFAP2B):c.218C>G (p.Pro73Arg) | 7021 | TFAP2B | Pathogenic | 80338910 | RCV000008510; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50791256 | 50791256 | NM_003221.3:c.218C>G | NP_003212.2:p.Pro73Arg | NC_000006.11:g.50791256C>G | OMIM Allelic Variant:601601.0006 | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.444C>A (p.Asp148Glu) | 7021 | TFAP2B | Benign | 13216733 | RCV000020530; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50791482 | 50791482 | NM_003221.3:c.444C>A | NP_003212.2:p.Asp148Glu | NC_000006.11:g.50791482C>A | - | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.601+5G>A | 7021 | TFAP2B | Pathogenic | 80338911 | RCV000020531; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50796397 | 50796397 | NM_003221.3:c.601+5G>A | | NC_000006.11:g.50796397G>A | - | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.706C>T (p.Arg236Cys) | 7021 | TFAP2B | Pathogenic | 80338912 | RCV000008507; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50803878 | 50803878 | NM_003221.3:c.706C>T | NP_003212.2:p.Arg236Cys | NC_000006.11:g.50803878C>A,NC_000006.11:g.50803878C>T | OMIM Allelic Variant:601601.0003 | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.706C>A (p.Arg236Ser) | 7021 | TFAP2B | Pathogenic | 80338912 | RCV000008508; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50803878 | 50803878 | NM_003221.3:c.706C>A | NP_003212.2:p.Arg236Ser | NC_000006.11:g.50803878C>A,NC_000006.11:g.50803878C>T | OMIM Allelic Variant:601601.0004 | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.772T>G (p.Ser258Ala) | 7021 | TFAP2B | Benign | 2817394 | RCV000020532; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50803944 | 50803944 | NM_003221.3:c.772T>G | NP_003212.2:p.Ser258Ala | NC_000006.11:g.50803944T>G | - | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.822-1G>C | 7021 | TFAP2B | Pathogenic | 80338916 | RCV000020533; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50805687 | 50805687 | NM_003221.3:c.822-1G>C | | NC_000006.11:g.50805687G>C | - | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.824C>A (p.Ala275Asp) | 7021 | TFAP2B | Pathogenic | 80338914 | RCV000008505; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50805690 | 50805690 | NM_003221.3:c.824C>A | NP_003212.2:p.Ala275Asp | NC_000006.11:g.50805690C>A | OMIM Allelic Variant:601601.0001 | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.854G>A (p.Arg285Gln) | 7021 | TFAP2B | Pathogenic | 80338915 | RCV000008509; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50805720 | 50805720 | NM_003221.3:c.854G>A | NP_003212.2:p.Arg285Gln | NC_000006.11:g.50805720G>A | OMIM Allelic Variant:601601.0005 | C1868570 169100 Char syndrome | | |
NM_003221.3(TFAP2B):c.898C>T (p.Arg300Cys) | 7021 | TFAP2B | Pathogenic | 80338917 | RCV000008506; | N | MedGen:C1868570,OMIM:169100,ORPHA:46627 | 6 | 50805764 | 50805764 | NM_003221.3:c.898C>T | NP_003212.2:p.Arg300Cys | NC_000006.11:g.50805764C>T | OMIM Allelic Variant:601601.0002 | C1868570 169100 Char syndrome | | |